January 23, 2023
Via: Biopharm InternationalThe FDA is issuing a new guidance to support sponsors in the development of drugs for monkeypox (mpox). The guidance is intended to provide nonclinical, virology, and clinical considerations for mpox drug development programs, targeting on recommendations to support initiation […]
July 19, 2024
July 11, 2024
July 11, 2024